Presentation

Primary Results of the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)

Presenter: Marco Valgimigli

REGISTER for free or LOG IN to view this content

Ticagrelor Monotherapy Beyond One Month Versus Conventional Therapy On Adjudicated Ischemic And Bleeding Endpoints Following Drug Eluting Sent Implantation. Primary Results of the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)
Clinical Cardiology
Clinical Pharma
Presentation
ACC 2019
Ticagrelor
GLASSY
GLOBAL LEADERS

Up Next

More slides +

We Recommend